EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ibudilast‐Mediated Suppression of Neuronal TLR4 in the Prefrontal Cortex Mitigates Methamphetamine‐Induced Neuroinflammation and Addictive Behaviours

Fangmin Wang iD, Huizhen Liu, Yuting Ke, Xiaolei Huang, Shanshan Chen, Dingding Zhuang, Yiying Zhou, Manqing Wu, Yuting Wang, Miaojun Lai, Huifen Liu, Wenhua Zhou

Addiction Biology · 2025

DOI: 10.1111/adb.70033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction Biology, 2025. Verfasst von Fangmin Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Lab of Addiction Research, The Affiliated Kangning Hospital of Ningbo University, Ningbo, People's Republic of China. Hauptthemen laut MEDLINE: Methamphetamine, Toll-Like Receptor 4, Prefrontal Cortex, Pyridines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Ningbo Top Medical & Health Research Program, Ningbo Key Research & Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methamphetamine (METH) use leads to addiction, neurotoxicity, and neuroinflammation. Ibudilast, a toll‐like receptor 4 (TLR4) inhibitor, has been shown to reduce METH‐induced neuroinflammation and self‐administration, but its specific role in neuronal TLR4 signalling and associated behavioural outcomes remains poorly understood. This study examined Ibudilast's effects on METH reward, drug‐seeking behaviour, and TLR4 signalling in a rat self‐administration model. Ibudilast was found to dose‐dependently reduce METH intake and motivation for the drug, as evidenced by a downward shift in the dose–response curve and a decrease in breakpoint. Additionally, Ibudilast suppressed both cue‐ and METH priming‐induced drug‐seeking behaviours. Western blot analysis revealed elevated TLR4, p‐NF‐κB and IL‐6 in the prefrontal cortex after 14 days of METH self‐administration. These increases were significantly attenuated by Ibudilast treatment. Furthermore, local administration of Ibudilast in the prefrontal cortex led to a reduction in METH intake and motivation, as well as decreased TLR4 expression in this brain region. Immunofluorescence staining was revealed that TLR4 was expressed predominantly in neurons and microglia, with METH‐induced upregulation of neuronal TLR4 being linked to apoptosis. Ibudilast restored normal spatial interactions between neurons and microglia, thereby mitigating neuroinflammation and neuronal damage. Furthermore, local injection of Ibudilast in the prefrontal cortex led to a reduction in METH intake and motivation, as well as decreased expression of TLR4 in the brain region. These findings underscore the critical role of neuronal TLR4 in METH addiction and highlight Ibudilast's therapeutic potential in addressing METH‐related neuroinflammation and behavioural dysregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethamphetamineToll-Like Receptor 4Prefrontal CortexPyridinesCentral Nervous System StimulantsNeuroinflammatory DiseasesAmphetamine-Related DisordersAnimalsRatsMaleRats, Sprague-DawleyDrug-Seeking BehaviorNeuronsSelf AdministrationMotivationRewardIndolizinesPyrazoles

Stichwörter der Autor:innen

addictiondrug use disordersmethamphetaminemicrogliapsychostimulanttoll‐like receptor

Substanzen

ibudilastMethamphetamineToll-Like Receptor 4PyridinesTlr4 protein, ratCentral Nervous System StimulantsIndolizinesPyrazoles

Autor:innen und Institutionen

  • Zhejiang Provincial Key Lab of Addiction Research, The Affiliated Kangning Hospital of Ningbo University, Ningbo, People's Republic of China.
  • Department of Psychiatry, The Affiliated Kangning Hospital of Ningbo University, People's Republic of China.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Department of Obstetrics, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, P. R. China.
  • Shanghai Mental Health Center, Shanghai, People's Republic of China.

ORCID-Profile: Fangmin Wang

Förderung

  • National Natural Science Foundation of China
  • Ningbo Top Medical & Health Research Program
  • Ningbo Key Research & Development Program

Zitieren

APA

Wang, F., Liu, H., Ke, Y., Huang, X., Chen, S., Zhuang, D., Zhou, Y., Wu, M., Wang, Y., Lai, M., Liu, H., & Zhou, W. (2025). Ibudilast‐Mediated Suppression of Neuronal TLR4 in the Prefrontal Cortex Mitigates Methamphetamine‐Induced Neuroinflammation and Addictive Behaviours. Addiction Biology. https://doi.org/10.1111/adb.70033

Vancouver

Wang F, Liu H, Ke Y, Huang X, Chen S, Zhuang D, et al. Ibudilast‐Mediated Suppression of Neuronal TLR4 in the Prefrontal Cortex Mitigates Methamphetamine‐Induced Neuroinflammation and Addictive Behaviours. Addiction Biology. 2025. doi:10.1111/adb.70033

BibTeX
@article{Wang2025,
  author = {Wang, Fangmin and Liu, Huizhen and Ke, Yuting and Huang, Xiaolei and Chen, Shanshan and Zhuang, Dingding and Zhou, Yiying and Wu, Manqing and Wang, Yuting and Lai, Miaojun and Liu, Huifen and Zhou, Wenhua},
  title = {Ibudilast‐Mediated Suppression of Neuronal TLR4 in the Prefrontal Cortex Mitigates Methamphetamine‐Induced Neuroinflammation and Addictive Behaviours},
  journal = {Addiction Biology},
  year = {2025},
  doi = {10.1111/adb.70033}
}
Kostenlos starten →